Suppr超能文献

采用三维图像分析比较低结晶碳酸磷灰石和 Bio-Oss 在鼻窦提升中的性能。

Comparison of the performances of low-crystalline carbonate apatite and Bio-Oss in sinus augmentation using three-dimensional image analysis.

机构信息

Department of Oral and Maxillofacial Implantology, Kanagawa Dental University, 82 Inaoka-cho, Yokosuka, 238-8580, Japan.

出版信息

Int J Implant Dent. 2021 Mar 23;7(1):24. doi: 10.1186/s40729-021-00303-4.

Abstract

BACKGROUND

In locations where the alveolar bone height is low, such as at the maxillary molars, implant placement can be difficult, or even impossible, without procedures aimed at generating new bone, such as sinus lifts. Various types of bone graft materials are used after a sinus lift. In our study, a three-dimensional image analysis using a volume analyzer was performed to measure and compare the volume of demineralized bovine bone mineral (Bio-Oss®) and carbonate apatite (Cytrans®) after a sinus lift, as well as the amount of bone graft material resorption. Patient data were collected from cone-beam computed tomography images taken before, immediately following, and 6 months after the sinus lift. Using these images, both the volume and amount of resorption of each bone graft material were measured using a three-dimensional image analysis system.

RESULTS

The amount of bone resorption in the Bio-Oss®-treated group was 25.2%, whereas that of the Cytrans®-treated group was 14.2%. A significant difference was found between the two groups (P < 0.001).

CONCLUSIONS

Our findings indicate that the volume of bone resorption was smaller in the Cytrans®-treated group than in the Bio-Oss®-treated group, suggesting that Cytrans® is more promising for successful implant treatments requiring a sinus lift.

摘要

背景

在牙槽骨高度较低的部位,如在上颌磨牙区,若不进行旨在生成新骨的手术,如窦提升术,种植体的植入可能会很困难,甚至不可能。在窦提升术后,会使用各种类型的骨移植材料。在我们的研究中,使用体积分析器进行了三维图像分析,以测量和比较窦提升术后脱矿牛骨矿物质(Bio-Oss®)和碳酸磷灰石(Cytrans®)的体积以及骨移植材料吸收量。从接受窦提升术前、即刻和术后 6 个月的锥形束 CT 图像中收集患者数据。使用这些图像,使用三维图像分析系统测量了每种骨移植材料的体积和吸收量。

结果

Bio-Oss®治疗组的骨吸收量为 25.2%,而 Cytrans®治疗组的骨吸收量为 14.2%。两组之间存在显著差异(P < 0.001)。

结论

我们的研究结果表明,Cytrans®治疗组的骨吸收量小于 Bio-Oss®治疗组,这表明 Cytrans®在需要窦提升的成功种植体治疗中更有前途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/419d/7985233/47dd4dcc2946/40729_2021_303_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验